Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
35991 | 88 | 29.3 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
315 | 3 | ALLERGY//MAST CELLS//BRADYKININ | 39886 |
3090 | 2 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA | 2362 |
35991 | 1 | MOEXIPRIL//CAS 82586 52 5//24 HOUR BLOOD PRESSURE MEASUREMENT ABPM | 88 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MOEXIPRIL | authKW | 5551920 | 27% | 67% | 24 |
2 | CAS 82586 52 5 | authKW | 693992 | 2% | 100% | 2 |
3 | 24 HOUR BLOOD PRESSURE MEASUREMENT ABPM | authKW | 346996 | 1% | 100% | 1 |
4 | 24 HOUR BLOOD PRESSURE MEASUREMENTS ABPM | authKW | 346996 | 1% | 100% | 1 |
5 | ABT TOXIKOL EXPT BIOL | address | 346996 | 1% | 100% | 1 |
6 | ACE INHIBITOR RAMIPRIL | authKW | 346996 | 1% | 100% | 1 |
7 | ANTIHYYPERTENSIVE THERAPY | authKW | 346996 | 1% | 100% | 1 |
8 | CALCIUM ANTAGONIST FELODIPINE | authKW | 346996 | 1% | 100% | 1 |
9 | CHANGES IN VASCULAR STRUCTURE AND FUNCTION | authKW | 346996 | 1% | 100% | 1 |
10 | CI 925 | authKW | 346996 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 512 | 23% | 0% | 20 |
2 | Cardiac & Cardiovascular System | 407 | 27% | 0% | 24 |
3 | Pharmacology & Pharmacy | 189 | 28% | 0% | 25 |
4 | Geriatrics & Gerontology | 132 | 7% | 0% | 6 |
5 | Gerontology | 56 | 3% | 0% | 3 |
6 | Medicine, General & Internal | 40 | 11% | 0% | 10 |
7 | Obstetrics & Gynecology | 14 | 5% | 0% | 4 |
8 | Women’s Studies | 11 | 1% | 0% | 1 |
9 | Nursing | 10 | 2% | 0% | 2 |
10 | Primary Health Care | 10 | 1% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABT TOXIKOL EXPT BIOL | 346996 | 1% | 100% | 1 |
2 | OFF P IDENTIAL AFFAIRS RUSSIAN FEDERAT | 346996 | 1% | 100% | 1 |
3 | SERV CARDIOL ANGIOL | 346996 | 1% | 100% | 1 |
4 | WAR MEM HOSP | 346996 | 1% | 100% | 1 |
5 | YEKATERINBURG CLIN DIAGNOST | 346996 | 1% | 100% | 1 |
6 | GERIATR EDUCA CLIN | 173497 | 1% | 50% | 1 |
7 | HYPERTENS DIS SECT | 57829 | 2% | 8% | 2 |
8 | OKLAHOMA CARDIOVASC HYPERTENS | 31543 | 1% | 9% | 1 |
9 | CARE COUNSELING | 21685 | 1% | 6% | 1 |
10 | CATTEDRA SEMEIOT MED | 21685 | 1% | 6% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF HUMAN HYPERTENSION | 6067 | 9% | 0% | 8 |
2 | KARDIOLOGIYA | 5317 | 11% | 0% | 10 |
3 | PERFUSION | 4254 | 2% | 1% | 2 |
4 | RUSSIAN JOURNAL OF CARDIOLOGY | 2955 | 2% | 0% | 2 |
5 | CARDIOVASCULAR THERAPY AND PREVENTION | 1859 | 2% | 0% | 2 |
6 | AMERICAN JOURNAL OF HYPERTENSION | 1467 | 6% | 0% | 5 |
7 | NIEREN-UND HOCHDRUCKKRANKHEITEN | 1454 | 2% | 0% | 2 |
8 | CLINICS IN GERIATRIC MEDICINE | 1218 | 2% | 0% | 2 |
9 | JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION | 965 | 3% | 0% | 3 |
10 | ADVANCES IN THERAPY | 853 | 2% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OSTROUMOVA, OD , PAUKOV, SV , FROLOVA, LI , (2006) ANGIOTENSIN CONVERTING ENZYME INHIBITOR MOEXIPRIL IN THE TREATMENT OF ARTERIAL HYPERTENSION. POSSIBILITIES OF MOEXIPRIL IN THE TREATMENT OF POSTMENOPAUSAL WOMEN.KARDIOLOGIYA. VOL. 46. ISSUE 11. P. 92-98 | 12 | 100% | 0 |
2 | BROGDEN, RN , WISEMAN, LR , (1998) MOEXIPRIL - A REVIEW OF ITS USE IN THE MANAGEMENT OF ESSENTIAL HYPERTENSION.DRUGS. VOL. 55. ISSUE 6. P. 845 -860 | 16 | 70% | 17 |
3 | CHRYSANT, SG , CHRYSANT, GS , (2004) PHARMACOLOGICAL AND CLINICAL PROFILE OF MOEXIPRIL: A CONCISE REVIEW.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 44. ISSUE 8. P. 827-836 | 20 | 35% | 9 |
4 | IVLEVA, AJ , (2006) INVESTIGATION OF EFFICACY OF CARDIOVASCULAR DRUGS IN WOMEN.KARDIOLOGIYA. VOL. 46. ISSUE 3. P. 85-89 | 9 | 69% | 0 |
5 | IVLEVA, AYA , ANDREEVSKAYA, EM , BURKOV, SG , (2009) PREVENTIVE PHARMACOTHERAPY IN ARTERIAL HYPERTENSION: PROBLEMS OF CLINICAL ASSESSMENT OF DRUGS IN WOMEN.KARDIOLOGIYA. VOL. 49. ISSUE 7-8. P. 71-75 | 6 | 60% | 0 |
6 | KHLOPONIN, DP , KROTOVA, YN , IVANOV, IV , (2007) PHARMACOLOGY OF MODERN ACE INHIBITORS: MOEXIPRIL EXAMPLE.CARDIOVASCULAR THERAPY AND PREVENTION. VOL. 6. ISSUE 5. P. 99-106 | 5 | 63% | 0 |
7 | GIETL, R , FRIEHE, H , NEY, P , (1998) PRECLINICAL SAFETY STUDIES OF THE COMBINATION MOEXIPRIL HYDROCHLORIDE HYDROCLOROTHIAZIDE.ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH. VOL. 48. ISSUE 4. P. 365-370 | 4 | 67% | 1 |
8 | IVANOVA, NV , LAZAREVA, VI , KOVANKO, GN , (2006) THE USE OF MOEXIPRIL IN ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTMCTUVE PULMONARY DISEASE.KARDIOLOGIYA. VOL. 46. ISSUE 2. P. 35-36 | 2 | 100% | 0 |
9 | KOLBASNIKOV, SV , BAKHAREVA, ON , (2006) CLINICAL, VEGITATIVE AND COGNITIVE DISORDERS IN HYPERTENSIVE POSTMENOPAUSAL WOMEN IN RELATION TO MENOPAUSE CAUSES.TERAPEVTICHESKII ARKHIV. VOL. 78. ISSUE 10. P. 64-67 | 2 | 100% | 0 |
10 | CAWELLO, W , BOEKENS, H , WAITZINGER, J , MILLER, U , (2002) MOEXIPRIL SHOWS A LONG DURATION OF ACTION RELATED TO AN EXTENDED PHARMACOKINETIC HALF-LIFE AND PROLONGED ACE INHIBITION.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. VOL. 40. ISSUE 1. P. 9 -17 | 6 | 32% | 3 |
Classes with closest relation at Level 1 |